Micah Parsons trade has 'poison pill' blocking future deal to Eagles - ESPN

Packers star pass rusher Micah Parsons will line up Monday night against the Eagles. The Cowboys went out of their way last summer to ensure Parsons would not play for the division rival Eagles — at least not anytime soon.

Unbeknownst to everyone except the few who crafted the August blockbuster trade that sent Parsons from Dallas to Green Bay was a little-known «poison pill» condition that, according to sources involved with the deal, prevents the two-time All-Pro from playing for Philadelphia in the immediate future.

The previously unreported condition states that if the Packers decide to trade Parsons to a team in the NFC East division — the Eagles tried to trade for him last summer before being rebuffed — then Green Bay would owe Dallas its 2028 first-round draft pick, sources involved in the trade told ESPN.

The poison pill condition also was used on Kenny Clark, the other player involved in the trade, according to sources. If the Cowboys trade Clark to a team in the NFC North, they then would owe the Packers their 2028 first-round pick.

League sources said these poison pill conditions clearly and smartly were put into place to block Parsons from winding up in Philadelphia, not far from where he grew up and one day wanted to play. The poison pill conditions apply to this season and 2026, according to sources, meaning the Packers don't have a clear path to trade Parsons to another NFC East team until 2027 at the earliest.

The Packers deployed a poison pill in a trade before — trying to block Brett Favre from going to the Minnesota Vikings.

In August 2008, when the Packers traded Favre to the New York Jets, they included a provision in the language of those trade papers that said if the Jets then traded Favre to an